| NCT Number | NCT07043504 |
| Lead Sponsor | Shengjing Hospital |
| Conditions | Insulin-Like Growth Factor I |
| Enrollment | 100 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2026-12-31 (estimated) |
| Study Completion | 2026-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2025-06-29 |